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Soluble Triggering Receptor Expressed on Myeloid Cells-1 as a marker to 
differentiate septic from aseptic meningitis in children: comparison with 
procalcitonin and C-reactive protein 
INTRODUCTION 
Acute meningitis in children is mainly aseptic 
and does not require specific treatment1. On the 
other hand, the mortality and disabling neurological 
sequelae from septic meningitis among children are 
significant making early differentiation between 
aseptic and septic meningitis cases a must2,3. As 
early warning signs and symptoms are often non-
specific, and the routine examination of 
cerebrospinal fluid (CSF) and blood is sometimes 
misleading4,5, a rapid and reliable test that 
accurately predicts sepsis is needed. It would open 
up an opportunity to initiate antibiotic treatment 
early and identify children at highest risk of poor 
outcome especially in developing countries in 
whom second line antibiotics therapy might be 
targeted3,4, 6. 
Various diagnostic markers have been 
suggested to facilitate such aims. These markers 
include the routine C-reactive protein (CRP)7, the 
powerful and massively studied procalcitonin 
(PCT)2,8-10 as well as the newly proposed, soluble 
triggering receptor expressed on myeloid cells-1 
(sTREM-1)11,12. CRP, a molecular mass of 120 kDa 
with a gene location between 1q21 and 1q23, is an 
important component of innate defense system 
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against infections13. It recognizes the 
phosphocholine on the surface of many bacteria, 
activates the classical complement pathway and 
facilitates phagocytosis by neutrophils. Due to the 
lack of its specificity, it is used as an additional 
marker with more conventional parameters such as 
number of leukocytes in CSF, blood count and 
protein level to help the clinician make a 
differential diagnosis14-16. 
PCT, the calcitonin precursor propeptide, is a 
13 kDa protein that is synthesized in C-cells of the 
thyroid gland and secreted from leukocytes of the 
peripheral blood17. Its gene is located on the short 
arm of chromosome 11 (11p15.4)16. The secretion 
of PCT was found to increase up to several 
thousand-fold in the presence of bacterial sepsis but 
remains normal or slightly increases in viral 
infections and inflammatory reactions that are not 
infectious18,19. In contrast to CRP levels which rise 
between 12 and 18 hours after bacterial challenge20, 
PCT concentration increases in the serum within 
two to three hours of the beginning of infection, 
peaking by 6–12 hours, and returning to normal 
concentrations within two days21. PCT is stable in 
plasma with plasma half-life of approximately 22 
hours. It is also extremely stable in vitro, unlike 
most cytokines, which makes it not only a 
promising new marker for early and sensitive 
identification of infected patients, but also for 
titration of response to the treatment10,19,22-25. Still, 
PCT is less than a perfect marker as it can be 
increased in non-infectious conditions, and may 
remain low in infections26. Additionally, 
interpretation of the studies dealing with PCT is 
complicated by variation in the choice of the 
abnormal cut of value, and by the diverse age range 
and nature of the study populations22. 
On the other hand, TREM-1 is a trans-
membrane glycoprotein cell-surface receptor of 
immunoglobulin superfamily which acts in 
cooperation with toll-like receptors (TLRs) under 
the control of nuclear factor- (NF-)27.The 
expression of TREM-1 is up-regulated on 
phagocytic cells in the presence of bacteria and 
fungi, triggering the secretion of the pro-
inflammatory cytokines that amplify the host 
response to these microbial agents28,29. TREM-1 is 
shed from the membrane of activated phagocytes 
and is present in a soluble form, sTREM-1, in body 
fluids. As data demonstrated that expression of 
membrane-bound TREM-1 on neutrophils and 
monocytes/ macrophages is strongly altered during 
sepsis, as is the release of its soluble form with 6 
hours peaking, it was highlighted that this protein 
may be useful in the diagnosis of sepsis27, 30. 
The aim of this study was to evaluate the 
diagnostic and prognostic utility of these markers in 
septic meningitis and their usefulness in early 
distinguishing between septic and aseptic 
meningitis in Egyptian children presenting with 




Fifty-one children (age range: 2-162 months, mean 
± SD: 59.1± 31.4, male vs female 29: 22) identified 
as possible cases of meningitis who were admitted 
to Pediatric Department in Tanta University 
Hospital between June 2008 to August 2010, were 
included in this case control prospective study. 
Patients were excluded if they had received 
parenteral antibiotics in the past seven days or had 
co-existing morbidities. Informed signed consent 
was obtained from parents for their children to 
participate in the study. 
Meningitis was defined as being septic or 
aseptic according to WHO case definition criteria31: 
children presenting with clinical symptoms of 
meningitis; fever, headache, stiff neck, bulging 
fontanelle or mental status changes, CSF with an 
elevated protein (>100 mg/dl), decreased glucose 
(<40 mg/dl) or leukocytosis (white blood cell 
(WBC) count >100/mm3) with at least 80% 
neutrophils and identification of bacteria directly by 
Gram stain smears or cultures from blood or CSF or 
indirectly by latex agglutination test of CSF. 
Aseptic meningitis was defined as the presence of 
acute onset of meningitis symptoms, WBC of 
>5/mm3 of which >50% were 
mononuclear/lymphocyte cells with the absence of 
any bacterial meningitis laboratory criteria. 
Accordingly, 36 cases had a final diagnosis of 
meningitis.  They were 22 males, and 14 females, 
aged 2 to 162 months (mean±SD: 59.7±32.3). 
Septic meningitis was diagnosed in 16 patients 
(mean age±SD: 56.6±30.6, males vs females 9:7) 
and aseptic meningitis in 20 cases (mean age ± SD: 
58.3±31.4, males vs females 9:11).  
Control group: 
The control group (15 cases) was defined by 
absence of inflammatory cells in CSF (WBC 
<5/mm3) and sterile bacteriologic findings in 
afebrile children with positive meningeal signs. 
They were 7 males and 8 females with a mean age 
of 55.4±31.8 (range 4-151 months). 
Protocol: 
Upon admission, the following items were 
recorded for each enrolled patient: age, sex, vital 
signs as well as clinical symptoms and signs. Blood 
samples were withdrawn for routine laboratory 
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investigations including erythrocyte sedimentation 
rate (ESR) by Westerngren method, CRP using a 
nephelometric assay (Dade-Behring, France), WBC 
counts and blood culture, in addition to PCT and 
sTREM-1 measurement. CSF samples were 
examined for protein, glucose, total and differential 
WBC. After centrifugation the deposits were 
subjected to Gram stained examination and 
microbiological culture. Latex agglutination tests 
using the Wellcogen bacterial antigen kit (Abbott 
Murex Biotech,  UK) were performed on CSF 
samples suggestive of meningitis, but with negative 
staining. After 48-72 hours of treatment, CRP, 
serum PCT and sTREM-1 levels were re-assessed 
for patients with meningitis only. Prognosis of 
cases was followed over a period of 7 days. 
Methods: 
Microbiological Cultures: 
Blood and CSF samples were collected under 
complete aseptic conditions according to the 
standardized techniques32. Microbiological 
cultivation and identification with detection of 
antibiogram of isolated organisms were carried out 
in Microbiology and Immunology Department, 
Tanta Faculty of Medicine, Egypt. Blood samples 
(3-5 ml) were cultured in blood culture bottles 
(Egyptian diagnostic media [EDM], Egypt), 
incubated at 37°C and examined each 48h for 
turbidity. Subculture from blood culture flasks and 
culture of CSF deposits were made on sheep blood 
agar, incubated both aerobically and anaerobically 
at 37°C for 48 -72h and any growth was identified 
according to the standard microbiological protocol. 
The performance of antibiotic sensitivity test and 
the results were guided by the Clinical and 
Laboratory Standards Institute (CLSI) guidelines33. 
Serum analysis: 
Procalcitonin assay:  
PCT was measured in duplicate by a specific 
immunoluminometric assay (LUMItest®, Brahms 
Diagnostica GmbH, Germany). Luminescence was 
measured automatically on a Berilux Analyzer 250 
(Behring Diagnostics, Germany). The detection 
limit was 0.08 ng/ml, and the intra-assay 
coefficients of variation at low and high 
concentrations were 12% and 5%, respectively. The 
normal serum procalitonin with this is 0.5 ng/ml. 
Soluble Triggering Receptor Expressed on Myeloid 
cells-1 ELISA: 
sTREM-1 was measured by commercially 
available human ELISA kit according to the 
manufacturer’s instructions (Quantikine Human 
TREM-1 Immunoassay, R&D Systems, USA) using 
mouse monoclonal antibody specific for human 
TREM-1. The mean minimum detectable dose was 
13.8 pg/ml with intra-assay variability of 3-7% and 




It was performed by using SPSS for Windows, 
version 9. Data were expressed as range and mean± 
standard deviation (SD)/median or numbers and 
percentages. Receiver operator characteristic (ROC) 
plots were performed using MedCalc software to 
determine the areas under the curve (AUCs) with 
95% confidence intervals for the three markers to 
predict septic meningitis. Differences between 
groups in continuous variables were tested for 
significance with the Mann-Whitney test while 
univariate analysis was done by Fisher's exact test. 





Out of 51 children enrolled in this study, 36 
(70.6%) had a final diagnosis of meningitis.  They 
were 22 (61%) males, and 14 (39%) females, aged 
2 to 162 months (mean ± SD: 59.7±32.3). Septic 
meningitis was diagnosed in 16 (44%, mean 
age±SD: 56.6±30.6, males vs females 9:7) and 
aseptic meningitis in 20 (56%, mean age±SD: 
58.3±31.4, males vs females 9:11). Fifteen children 
(7 males and 8 females) with age range of 4-151 
months (mean±SD 55.4±31.8) were proven to be 
non-meningitis cases and served as controls. Eleven 
of those children were diagnosed with epilepsy and 
4 with relapse-free acute lymphoblastic leukemia. 
There was no difference between the studied groups 
with respect to age or sex (P0.05).  
The common manifestations at the time of 
diagnosis in the meningitis groups were fever, 
headache, nausea or vomiting and convulsions 
while in the control group were convulsions and 
nausea or vomiting (figure 1). In the 44% infected 
cases of bacteriological origin, 7 (43.7%) were 
found to be Neisseria meningitidis, 5 (31.3%) 
Haemophilus influenzae, 3 (18.7%) Streptococcus 
pneumoniae and 1 (6.3%) Liesteria. The CSF Gram 
staining, CSF culture, CSF soluble antigens and 
blood culture results showed sensitivity of 68.8% 
(11/16), 81.3% (13/16), 31.3% (5/16) and 25% 









































































Septic meningitis group (n = 16)
Aseptic  meningitis group (n = 20)
Control  group (n = 15)
  
Fig. 1: Clinical manifestations of the studied groups 
 
Routine blood parameters differed significantly 
between patients with bacterial and aseptic 
meningitis (table 1). WBC counts and ESR levels 
were significantly higher in patients with septic 
meningitis than patients with aseptic meningitis and 
controls at the time of diagnosis (P0.001). On the 
other hand, patients with aseptic meningitis had 
significantly higher WBC (P <0.05) than in control 
group, but with no significant difference regarding 
ESR (P >0.05). 
CSF laboratory findings are shown in table 1. 
Patients with septic meningitis had significantly 
increased CSF protein, WBC count and neutrophil 
percentage in comparison with both aseptic 
meningitis and control groups (P <0.0001), while 
CSF glucose level was significantly lower in 
patients with septic meningitis than in patients with 
aseptic meningitis (P=0.001) and controls (P 
=0.01).  
Baseline CRP, PCT and sTREM-1 levels were 
significantly higher in patients with septic 
meningitis than in patients with aseptic meningitis 
and control groups with P values at or less than 
0.0001. On the other hand, patients with aseptic 
meningitis had significantly higher CRP value 
(P=0.014) than in control group, but with no 
significant difference regarding serum PCT and 
sTREM-1 levels (P >0.05) (table 2). After 48h, 
there was no significant difference in CRP 
(P=0.09), PCT (P=0.28) and sTREM-1 (P=0.23) 
levels compared to their levels at admission in 
aseptic meningitis group. On the contrary, CRP 
(P=0.02), PCT (P=0.04) and sTREM-1 (P=0.03) 
values were significantly reduced 48-72h after 
admission compared to their baseline values in the 
septic meningitis group. The level of these markers 
were significantly higher in septic than non septic 
group after 48-72h (P=0.003, PCT: P=0.0001 and 
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Table 1. Comparison of the routine blood and CSF laboratory findings in the studied groups. 
Parameters 
Septic meningitis 
(n = 16) 
Aseptic meningitis 
(n = 20) 
Control 
(n = 15) 
T-test p value 
Blood  
3.7a 0.0007 
5.3 b 0.0001 WBC (x109/mm3) 
17.3 ± 7.9 
(7.2-22.6) 
10.7 ± 4.3 
(4.4-12.8) 
6.3 ± 1.7 
(2.5-8.1) 
3.2 c 0.003 
0.2 a 0.8 
2.3 b 0.03 ESR(mm/h) 
29.5 ± 16.3 
(12.7-45.9) 
19.1 ± 10.6 
(8.8-28.4) 
17.9 ± 5.2 
(7.2-20.6) 2.3 c 0.03 
Cerebrospinal fluid (CSF)  
1.4 a 0.2 





(20-43) 5.6 c 0.0001 
0.2 a 0.8 







3.6 c 0.001 
6.8 a 0.0001 






4.5 c 0.0001 
14.6 a 0.0001 






33.9 c 0.0001 
Values are mean ± SD (range); WBC: white blood cell count; ESR: erythrocyte sedimentation rate. 
a  Control group vs aseptic meningitis group;  
b  Control group vs septic meningitis group;  
c aseptic meningitis group vs septic meningitis group  
*P0.05 is significant using Mann-Whitney test.  
 
Table 2. Comparison of CRP, PCT and sTREM serum levels on admission among the studied groups 
 Septic meningitis  
group 
(n = 16) 
Aseptic  meningitis  
group 
(n = 20) 
Control  
group 
(n = 15) 
Z p value 
-2.47a 0.014* 









-1.85 a 0.064 








-4.06 c 0.0001* 
-0.07 a 0.94 









-4.46 c 0.0001* 
Values are median (range); CRP: C-reactive protein, PCT: Procalcitonin, sTREM-1: soluble triggering receptor expressed on 
myeloid cells-1. 
a  Control group vs aseptic meningitis group;  
b  Control group vs septic meningitis group;  
c aseptic meningitis group vs septic meningitis group  
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Table 3. Sensitivity, specificity and positive and negative predictive values (%) of baseline CRP, PCT and 
sTREM values for septic meningitis. 








CRP 29 mg/l 81.2 (54.4- 96) 80 (63.1-91.6) 68.4 (62-71) 90.6 (88-95) 
PCT 3.3 ng/ml 87.5 (61.7-98.4) 88.6 (73.3-96.8) 82.4 (77-85) 94.1 (89-95) 
sTREM-1 12.4 ng/ml 93.7 (69.8 - 99.8) 94.3 (80.8 - 99.3) 88.2 (84-93) 97.1  (91-99) 
Optimum diagnostic cut off values derived from the ROC curve. CRP, C-reactive protein; PCT, procalcitonin; sTREM-1, soluble 
triggering receptor expressed on myeloid cells-1; CI, confidence interval; AUC of ROC, area under curve of the receiver operating 
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* P is significant (<0.05) on comparing baseline and 48-72h 
level of each marker 
** P is significant (<0.05) on comparing 48-72h level of the 
markers in septic and aseptic groups 
Figure 2. Comparison of CRP, PCT and sTREM-1 
serum levels at admission and after 48-72h. CRP: C-
reactive protein, PCT: Procalcitonin, sTREM-1: soluble 
triggering receptor expressed on myeloid cells-1. 
 
Median plasma sTREM-1 levels at admission 
were 4.6 ng/ml in aseptic meningitis cases and 25.2 
ng/ml in septic meningitis cases. As shown in figure 
3, plasma sTREM-1 levels yielded the highest 
discriminative value with area under the ROC curve 
being 0.94 (95% CI, 0.84 - 0.99). Although, this 
value did not show statistical significance when 
compared with that of PCT (0.92, 95% CI, 0.81 -
 0.98; P0.05), the difference became significantly 
evident for CRP (0.87, 95% CI, 0.75 - 0.95; 
P=0.03).  
The sensitivity, specificity, and positive and 
negative predictive values of CRP, PCT and 
sTREM-1 are shown in table 3. At a cutoff of 12.4 
ng/ml, sTREM-1 yielded a sensitivity of 93.7% and 
a specificity of 94.3% in differentiating patients 
with septic from those with aseptic meningitis. Of 
notice, the use of combination of sTREM-1 and 
PCT did not affect the sensitivity but increased the 
specificity to 97.1% with no improvement when 
CRP values were added.  
 


















Figure 3. Receiver operating characteristic (ROC) 
curves comparing baseline C-reactive protein 
(CRP), procalcitonin (PCT) and soluble triggering 
receptor expressed on myeloid cells-1 (sTREM-1) 
for prediction of septic meningitis. The area under 
the curve (95% CI) was 0.87 (0.75 - 0.95) for CRP, 




The use of these parameters as prognostic 
markers was also evaluated. Five (31.3%) of 16 
patients with septic meningitis showed poor 
outcome and died. Serum sTREM-1 level [median 
14.8 ng/ml (3.2-21.3) vs 43.3 ng/ml (11.8-64.9), 
Z=2.7; P=0.007) but not PCT [median 52.7 ng/ml 
(0.3-351.3) vs 81.2 ng/ml (3.2-425.5), Z=1.13, 
P=0.26) or CRP levels [median 64 ng/ml (28-241) 
vs 142 ng/ml (19-362), Z=0.17, P=0.87) 
concentrations were significantly lower at 
admission in patients with poor than in those with 
adequate outcome with plateau level (median 16.1 
ng/ml) after 48-72hs. Noticeably, the AUCs of 
ROC for CRP, PCT and sTREM-1 in predicting 
septic meningitis poor outcome were 0.53 (95% CI 
0.42–0.61), 0.62 (95% CI 0.58–0.71) and 0.87 
(95% CI 0.78–0.92), respectively.  
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DISCUSSION 
Establishing the diagnosis of septic meningitis is a 
cornerstone in preventing not only unnecessary 
antibiotic and hospital admission but also serious 
neurological damage or even death. Hence, 
management strategies have been oriented towards 
the use of combination of clinical and laboratory 
information such as CBC, neutrophil count, and 
CRP concentration with up to 40% possibility of 
overlap between septic and aseptic meningitis 
cases34. Intensive researches have been carried out 
to find new and rapid diagnostic methods for 
differential diagnosis of bacterial and viral 
meningitis with varying degrees of success and only 
few of them reported in children35. Therefore, this 
work aimed to evaluate the use of sTREM in 
comparison to PCT and CRP for early diagnosis 
and differentiation between septic and aseptic 
meningitis cases in Egyptian children with 
evaluation of their role as prognostic markers.  
Septic meningitis patients had significantly 
higher baseline PCT levels compared to aseptic 
meningitis cases and controls. This increase in PCT 
levels in bacterial meningitis may be due to 
extracellular multiplication of the causative 
encapsulated bacteria resulting in a strong systemic 
inflammatory response36,37.  
A variety of studies and reviews have shown 
the superior diagnostic accuracy of PCT as 
compared to other parameters for the diagnosis of  
sepsis,  independent  of  the  origin  of  
infection12,24-26. However, on reviewing the results 
of different studies carried out to evaluate PCT 
discriminative ability in detecting septic meningitis, 
controversy was clear with sensitivity and 
specificity ranging from 57% to 100%, and from 
50% to 100%, respectively8,12,22,36,38-41. While 
Hatherill et al.22 suggested that PCT measurement 
has the potential to shorten the duration of both 
antibiotic treatment and hospital stay for their 
febrile children, Hoffmann et al.,41 found that PCT 
serum concentrations did not differ between those 
suffering from bacterial meningitis and those with 
viral meningitis. Possible explanation for these 
divergent results could be the different laboratory 
methods used or the selected group of patients 
studied. 
Admission PCT level showed non significant 
higher discriminative power than CRP in 
distinguishing septic from aseptic meningitis in our 
study. However, there was significant elevation in 
CRP but not in PCT baseline values in aseptic 
meningitis cases compared to controls which points 
to better specificity of PCT as suggested by 
Hatherill et al.22 and clarified by Carrol et al.42 as 
differential kinetics of PCT and CRP. Our data are 
consistent with results of previous single-center 
studies among pediatric10,12,19,43,44 and adult8,40 
patients. On the other hand, Dubos et al.2 concluded 
that although PCT level is probably the best 
biological predictor currently available to 
distinguish between bacterial and aseptic 
meningitis, it cannot be used alone with 100% 
sensitivity and good specificity regardless of the 
threshold chosen. 
PCT cutoff value that gave the best sensitivity 
and specificity in differentiating septic from aseptic 
meningitis in this work was 3.3 ng/ml. 
Interpretation of the literature dealing with PCT is 
complicated by variation in the choice of the 
abnormal cutoff value22. Consistent with our 
finding, Carrol et al.42 pointed out that PCT value of 
2 ng/ml might help distinguish severe life 
threatening bacterial infection from localized and 
viral disease in febrile children. Similar conclusion 
was obtained by Marc et al.45 but with a low 
threshold value of <0.5 ng/ml. On the other hand 
Hatherill et al.22 estimated that an admission PCT 
value of 20 ng/ml might be used to distinguish 
children with septic meningitis with high sensitivity 
and specificity. Christ-Crain and Muller26 notified 
that clinically apparent infections are a sequel of 
complex and variable interactions between host 
immune response, microbes and their toxins thus, it 
is far too complex to be reduced to a single cutoff 
of any specific surrogate marker. 
In this study, serum sTREM was evaluated as a 
new maker in meningitis cases. It was also higher in 
septic meningitis cases but not in aseptic meningitis 
cases compared with controls. This may be due to 
bacterial loads which trigger systemic inflammation 
and increase sTREM-1 levels46. Moreover, serum 
sTREM cut off value of 12.4 ng/ml showed 
significantly higher sensitivity and specificity that 
reached more than 90% with best discriminative 
power when compared to PCT and CRP. This 
specificity may be based on the fact that LPS is the 
main inducer of TREM-1 expression and supported 
by the finding that stimulation of human monocytes 
with proinflammatory cytokines induced very small 
sTREM-1 release unless LPS was added as a 
costimulus29, 44, 45.  
Previous clinical studies have shown that 
sTREM-1 levels could differentiate critically ill 
patients with severe sepsis from those without11,27, 7. 
However, little is known about the role of sTREM 
in meningitis. In striking contrast to our result, 
Carrol et al.,12 in their comparative study of the 
accuracy of five serum markers in diagnosis of 
serious bacterial infections (SBI) including 
Hassan et al. 
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meningitis concluded that PCT but not sTREM-1 
was the best diagnostic and prognostic marker in 
SBI while PCT and CD163 were superior to other 
markers in predicting fatal outcome. However, 
measuring sTREM-1 in CSF, unlike PCT, was 
concluded to be upregulated in patients with 
bacterial meningitis with high specificity; its 
presence could potentially assist clinicians in the 
diagnosis of bacterial meningitis48,49. It is to be 
noted that our results are more practical because 
measurement of serum sTREM is much less 
invasive, can be observed regularly in blood 
samples and can be measured together with routine 
variables.  
The present work also attempted to evaluate the 
role of the studied parameters in monitoring the 
response to treatment. Three days after treatment of 
our septic meningitis cases, the decline of PCT and 
sTREM values was significant compared to 
baseline levels although it did not return to normal 
values as in the control group. This finding suggests 
that despite treatment, both parameters continue to 
be high for 48/72 hours and can be used for 
diagnosis for at least 48 h.19. It also clarifies the 
inflammatory role of these markers as mediators 
responsible for persistence of inflammatory 
manifestations2. Since these mediators decrease 
with successful treatment, they may be helpful for 
follow-up19. 
The prognostic importance of the studied 
markers was determined in this work. Unlike PCT 
and CRP, sTREM-1 concentration was significantly 
low at admission in patients with poor outcome 
with nearly stationary value after 48-72hs. 
Additionally, the low baseline sTREM-1 level was 
found to be the best prognostic factor of the poor 
outcome with the highest AUC value, denoting that 
elevated baseline sTREM-1 level could be a 
valuable predictive marker.  Our results support the 
experimental findings which indicated that the more 
the release of sTREM-1, the more favorable is the 
outcome50. Human findings showed that significant 
levels of sTREM-1 were released in the serum of 
critically ill patients with sepsis, the highest levels 
being observed in patients who survived47. 
The mechanism by which sTREM modulate the 
immune response is still unclear. However, the role 
of TREM-1 as an amplifier of a wide range of 
proinflammatory response was confirmed28,44. 
Moreover, blockade of TREM-1 signaling using 
synthetic peptide that mimic part of the 
extracellular domain of TREM-1 in a mouse model 
was found to reduce NF-B activation and cytokine 
production, thus protecting septic animals from 
hyper-responsiveness and death51. Along similar 
lines, elevated sTREM-1 concentrations observed 
in septic patients may block TREM-1 signaling11,40. 
Bouchon et al.28 suggested that the increase of 
sTREM could prevent the engagement of 
membrane TREM-1 and act as a decoy receptor, as 
in the TNF- system. Gibot et al.47 added that 
sTREM-1 may act as a negative feedback regulator 
of the inflammatory response making it a 
promising, therapeutic target.  
In conclusion, both serum PCT and sTREM are 
valuable in the early distinguishing of septic from 
aseptic meningitis in children but with markedly 
higher diagnostic discriminatory power for sTREM-
1. Moreover, this study pointed to the significant 
value of sTREM-1in determining septic meningitis 
prognosis. However, it remains to be confirmed in 
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